Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Taysha Gene Therapies Inc
TSHACurrent price
1.53 USD
-0.16 USD (-9.47%)
Last closed
1.69 USD
Company
www.tayshagtx.com
ISIN
US8776191061
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
407 836 576 USD
Yield for 12 month
-38.31 %
1Y
3Y
5Y
10Y
15Y
TSHA
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of for SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas. Address: 3000 Pegasus Park Drive, Dallas, TX, United States, 75247
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6.41 USDP/E ratio
–Dividend Yield
–Current Year
+15 451 000 USD
Last Year
+2 502 000 USD
Current Quarter
+1 112 000 USD
Last Quarter
+3 411 000 USD
Current Year
+14 080 000 USD
Last Year
+15 000 USD
Current Quarter
+812 000 USD
Last Quarter
+3 086 000 USD
Key Figures TSHA
1 year
3 years
5 years
10 years
EBITDA
-75 716 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-34.17 %
PEG Ratio
–
Return On Equity TTM
-318.69 %
Wall Street Target Price
6.41 USD
Revenue TTM
12 873 000 USD
Book Value
0.54 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-53.6 %
Dividend Yield
–
Gross Profit TTM
2 502 000 USD
Earnings per share
-0.49 USD
Diluted Eps TTM
-0.49 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics TSHA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TSHA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation TSHA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
22.7466
Price Sales TTM
31.6816
Enterprise Value EBITDA
-0.6061
Price Book MRQ
3.7462
Financials TSHA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TSHA
For 52 weeks
1.27 USD
4.32 USD
50 Day MA
2.1 USD
Shares Short Prior Month
20 644 679
200 Day MA
2.38 USD
Short Ratio
10.85
Shares Short
20 704 276
Short Percent
13.33 %
BeatStart